Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA announced marketing authorization of a form of ...
News Medical on MSN7d
USC researchers receive $6 million to advance dry AMD treatmentThe California Institute for Regenerative Medicine (CIRM), the state's stem cell agency, has awarded a two-year, $6 million ...
Hosted on MSN1mon
Common diabetes drug shows promise for treating macular degenerationThere is no cure for dry AMD, though lifestyle modifications and supplements may help slow its development. Wet AMD can be treated with monthly injections into the eye to slow its progression ...
"There are very few therapeutic options available for patients suffering with dry AMD," said Cioffi ... and involve direct injection of the drug into the eye. We are developing an orally ...
Shares in US biotech Iveric Bio have shot up after the company said its lead drug Zimura had slowed eyesight deterioration in patients with the dry form of age-related macular degeneration (AMD ...
The 5th Dry AMD and GA Therapeutics Summit will unite 80+ biopharma stakeholders, from discovery to early clinical development, across three days of focused discussion. This summit is the definitive ...
The US Food and Drug Administration (FDA) has granted marketing authorisation for LumiThera’s Valeda Light Delivery System to treat dry age-related macular degeneration (AMD). Valeda is said to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback